Building on this, Chalasani et al. outlined in their clinical guidance that broader metabolic screening, including glucose tolerance and insulin resistance assessments, should be routinely performed in patients suspected of having NAFLD [23]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.